Getinge AB (OSTO:GETI B) Tax Provision : kr-855 Mil (TTM As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Getinge AB Tax Provision?

Getinge AB's tax provision for the three months ended in Mar. 2024 was kr-174 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2024 was kr-855 Mil.

Getinge AB Tax Provision Historical Data

The historical data trend for Getinge AB's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Tax Provision Chart

Getinge AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-653.00

-1,213.00

-1,187.00

-956.00

-915.00

Getinge AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Provision	Get a 7-Day Free Trial															-233.00	-88.00	-326.00	-267.00	-174.00

Getinge AB Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-855 Mil.

Getinge AB (OSTO:GETI B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

GNGBY:USA GNGBF:USA GETIBs:UK 0GZV:UK GTN:Germany

Address

Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56

Website

https://www.getinge.com

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB (OSTO:GETI B) Headlines

No Headlines